Tag: Telix
Telix secures advanced biologics technology platform in strategic deal
Telix Pharmaceuticals has announced an asset purchase agreement with antibody engineering firm ImaginAb, Inc, marking the expansion of its capabilities in precision medicine and therapeutic innovation.
ASX-listed Telix Pharmaceuticals unveils potential plan for US listing
Melbourne-based biopharmaceutical giant Telix Pharmaceuticals announced today its plans for an initial public offering in the United States and listing on the Nasdaq Global...
Australian pharma firm Telix opens $21m radiopharmaceutical production facility in Belgium
ASX-listed Telix Pharmaceuticals has recently opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility in Belgium, serving as the primary manufacturing site for radioisotopes and commercial and clinical products for patients in the Europe Middle East and Africa (EMEA) region.
Advanced biologics manufacturing Consortium secures $1.1m SIEF grant
A consortium of industry collaborators consisting of CSIRO, GE Health, ThermoFisher and Telix have been awarded an $1.1m Science and Industry Endowment Fund (SIEF)...
Featured Article
Navigating energy price volatility with predictive intelligence
Energy price volatility has become a structural feature of modern electricity markets rather than a temporary disruption. For energy-intensive manufacturers and large commercial operators, fluctuating wholesale prices are reshaping how energy costs are managed, making reactive approaches increasingly inadequate.
